Date Title Description PDF
26 Jul 2023 On buy-back programmes The Company reports the commencement, effective as of today, 26 July 2023, of a share buyback program.   Download
10 May 2023 On P&L The Company releases the first quarter 2023 financial results presentation Download
10 May 2023 On P&L The Company releases the press release related to the first quarter 2023 financial results Download
25 Apr 2023 On business and financial situation ROVI commences clinical development of a new three-monthly formulation of Letrozole (Letrozole LEBE) Download
21 Feb 2023 About Corporate Governance The Company informs about the agreements adopted by the Board of Directors Download

Pages

Date Title Description PDF
13 May 2020 On business and financial situation ROVI releases the presentation related to the first quarter 2020 financial results Download
02 Apr 2020 Liquidity contracts and specialists Liquidity contract: transactions conducted in the first quarter of 2020 Download
02 Apr 2020 On business and financial situation ROVI informs on the impact of Covid‑19 on the company’s activities Download
26 Feb 2020 Information on P&L ROVI releases the press release related to the full year 2019 financial results Download
26 Feb 2020 Information on P&L ROVI releases the full year 2019 results presentation Download

Pages

Date Title Description PDF
20 Feb 2018 Información sobre resultados ROVI releases the presentation related to the full year 2017 results Download
20 Feb 2018 Información sobre resultados ROVI releases the press release related to the full year 2017 results Download
20 Feb 2018 Informe anual de remuneraciones de los consejeros ROVI releases the 2017 annual report regarding remuneration of the members of the Board of Directors Download
20 Feb 2018 Informe Anual de Gobierno Corporativo ROVI releases the 2017 Annual Corporate Governance Report Download
20 Feb 2018 Otros sobre gobierno corporativo The Company informs about the agreements adopted by the Board of Directors Download

Pages